$13.640
-0.331 (-2.43%)收盘时
价格预测
在 App 中打开以解锁更长周期的预测。
RNA 相似图表分析预测
Alphio's RNA stock price prediction model matches the current Atrium Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $13.64 (+0.03%). The 1-week path is $13.37 (-2.00%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
该买入 Atrium Therapeutics Inc 股票吗?
Avidity Biosciences Inc appears to be a good buy right now due to its current price of $13.64, which is significantly below the analyst price target of $25, suggesting a potential upside of 83.5%. Additionally, the stock has shown a positive 20-day change of +20.18%, indicating a recent upward trend. However, investors should be cautious of the high insider selling activity, which has increased by 200.63% over the last month, indicating potential concerns among insiders.
RNA 股价于 Friday 收于 $13.64,此前下跌 -2.43%
Atrium Therapeutics Inc (RNA) last closed at $13.64, losing -2.43%. These facts feed the 1-day and 1-week RNA price prediction above.
预测驱动因素
Atrium Therapeutics Inc(RNA)的预测驱动因素综合了相似的图表形态、季节性与移动平均线。
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bearish
相似图表形态
近期走势与 RNA 最接近的股票,按相似度排序。
RNA 季节性分析
Historically the probability of a positive August return for RNA is 68.25%. September offers the highest probability of a positive month at 100.00%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。